{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T09:04:38Z","timestamp":1781687078790,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejca.2025.116191","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:04:32Z","timestamp":1766563472000},"page":"116191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Braf-mutant metastatic non\u2013small-cell lung cancer: Real world data from the Italian biomarker atlas database"],"prefix":"10.1016","volume":"234","author":[{"given":"Claudio","family":"Sini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Cortinovis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Anna","family":"Muscarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Tiseo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Bria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Piovano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Veccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Antonuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Citarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pilotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia","family":"Reale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Pignataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Calvetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Pizzutilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Minuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Pelizzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Al\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Signorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Meoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Sergi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Genova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vieri","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Vaval\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pasello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Pedrazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Chiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"D\u2019Aveni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Buosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Toschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector Soto","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Buffoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigida","family":"Stanzione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Zannori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Giannarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Malapelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Novello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Passiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Editta","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2025.116191_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103118","article-title":"BRAF as a positive predictive biomarker: focus on lung cancer and melanoma patients","volume":"156","author":"Malapelle","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejca.2025.116191_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/1078-0432.CCR-18-2062","article-title":"Impact of BRAF mutation class on disease characteristics and clinical outcomes in BRAF-mutant lung cancer","volume":"25","author":"Dagogo-Jack","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2025.116191_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102335","article-title":"How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC)","volume":"103","author":"Tabb\u00f2","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejca.2025.116191_bib4","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S1470-2045(16)30146-2","article-title":"Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial","volume":"17","author":"Planchard","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.116191_bib5","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S1470-2045(17)30679-4","article-title":"Dabrafenib plus trametinib in patients with previously untreated BRAF(V600E)-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial","volume":"18","author":"Planchard","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.116191_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jtho.2021.08.011","article-title":"Phase 2 study of dabrafenib plus trametinib in patients with BRAF V600E-Mutant metastatic NSCLC: updated 5-year survival rates and genomic analysis","volume":"17","author":"Planchard","year":"2022","journal-title":"J Thorac Oncol"},{"issue":"43","key":"10.1016\/j.ejca.2025.116191_bib7","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_404770","article-title":"Expanding the benefit: dabrafenib\/trametinib as tissue-agnostic therapy for BRAF V600E-positive adult and pediatric solid tumors","author":"Gouda","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ejca.2025.116191_bib8","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1200\/JCO.23.00774","article-title":"Phase II, open-label study of encorafenib plus binimetinib in patients with BRAF(V600)-mutant metastatic non-small-cell lung cancer","volume":"41","author":"Riely","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.116191_bib9","doi-asserted-by":"crossref","first-page":"S1246","DOI":"10.1016\/j.annonc.2024.08.2298","article-title":"LBA56 Updated efficacy and safety from the phase II PHAROS study of encorafenib plus binimetinib in patients with BRAF V600E-mutant metastatic NSCLC (mNSCLC)","volume":"35","author":"Riely","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2025.116191_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107787","article-title":"The biomarkers ATLAS: an audit on 1100 non-small cell lung cancer from an Italian knowledge-based database","volume":"191","author":"Malapelle","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejca.2025.116191_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.108038","article-title":"Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): Results from the IFCT-2004 BLaDE cohort","volume":"199","author":"Swalduz","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejca.2025.116191_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123608","article-title":"Efficacy of dabrafenib plus trametinib combination in patients with BRAF V600E-mutant NSCLC in real-world setting: GFPC 01-2019","volume":"12","author":"Auliac","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejca.2025.116191_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cllc.2019.03.007","article-title":"Efficacy and safety of BRAF inhibitors with or without MEK inhibitors in BRAF-mutant advanced non-small-cell lung cancer: findings from a real-life cohort","volume":"20","author":"Dudnik","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ejca.2025.116191_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.lungcan.2018.12.003","article-title":"Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer","volume":"128","author":"Horn","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejca.2025.116191_bib15","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1158\/1078-0432.CCR-13-0657","article-title":"Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer","volume":"19","author":"Cardarella","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2025.116191_bib16","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1200\/JCO.2011.35.9638","article-title":"Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations","volume":"29","author":"Marchetti","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.116191_bib17","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(16)00004-0","article-title":"Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)","volume":"387","author":"Barlesi","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2025.116191_bib18","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2010.33.1280","article-title":"Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations","volume":"29","author":"Paik","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.116191_bib19","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/cncr.29042","article-title":"Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the lung cancer mutation consortium","volume":"121","author":"Villaruz","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2025.116191_bib20","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/j.cllc.2018.10.003","article-title":"Natural disease history, outcomes, and co-mutations in a series of patients with BRAF-mutated non-small-cell lung cancer","volume":"20","author":"Myall","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ejca.2025.116191_bib21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1056\/NEJMoa1904059","article-title":"Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma","volume":"381","author":"Robert","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2025.116191_bib22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/JTO.0000000000000191","article-title":"Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer","volume":"9","author":"O\u2019Malley","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ejca.2025.116191_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.14252\/foodsafetyfscj.D-22-00008","article-title":"Application of CYP1A2-template system to understand metabolic processes in the safety assessment","volume":"10","author":"Murayama","year":"2022","journal-title":"Food Saf"},{"key":"10.1016\/j.ejca.2025.116191_bib24","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1158\/0008-5472.CAN-20-3991","article-title":"Association between smoking history and tumor mutation burden in advanced non-small cell lung cancer","volume":"81","author":"Wang","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2025.116191_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.911303","article-title":"Clinical characteristics, co-mutations, and treatment outcomes in advanced non-small-cell lung cancer patients with the BRAF-V600E mutation","volume":"12","author":"Qu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2025.116191_bib26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/CAD.0000000000001623","article-title":"MET alterations as resistance mechanisms of dabrafenib-trametinib in BRAF p.V600E mutated non-small cell lung cancer patient","volume":"35","author":"Pluchino","year":"2024","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ejca.2025.116191_bib27","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1016\/j.cllc.2020.11.002","article-title":"MET amplification (MET\/CEP7 Ratio \u2265 1.8) is an independent poor prognostic marker in patients with treatment-naive non-small-cell lung cancer","volume":"22","author":"Yin","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ejca.2025.116191_bib28","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1158\/1078-0432.CCR-17-2961","article-title":"Concurrent alterations in EGFR-mutant lung cancers associated with resistance to EGFR Kinase inhibitors and characterization of MTOR as a mediator of resistance","volume":"24","author":"Yu","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2025.116191_bib29","article-title":"Clinical outcomes with dabrafenib plus trametinib in a clinical trial versus real-world standard of care in patients with BRAF-mutated advanced NSCLC","volume":"3","author":"Johnson","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.ejca.2025.116191_bib30","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/annonc\/mdz167","article-title":"Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry","volume":"30","author":"Mazieres","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2025.116191_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002891","article-title":"Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer","volume":"9","author":"Negrao","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejca.2025.116191_bib32","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1186\/s12885-024-12554-6","article-title":"Efficacy of chemotherapy plus immune checkpoint inhibitors in patients with non-small cell lung cancer who have rare oncogenic driver mutations: a retrospective analysis","volume":"24","author":"Yamaguchi","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2025.116191_bib33","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1186\/s12885-024-12748-y","article-title":"Clinical outcomes for immune checkpoint inhibitors plus chemotherapy in non-small-cell lung cancer patients with uncommon driver gene alterations","volume":"24","author":"Qin","year":"2024","journal-title":"BMC Cancer"},{"issue":"25","key":"10.1016\/j.ejca.2025.116191_bib34","first-page":"00706","article-title":"Treatment sequences in BRAF-V600-mutated non-small cell lung cancer: First-line targeted therapy versus first-line (chemo-) immunotherapy","volume":"S1556-0864","author":"Wiesweg","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ejca.2025.116191_bib35","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S1470-2045(25)00409-7","article-title":"First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study","volume":"26","author":"Di Federico","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.116191_bib36","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1200\/JCO.21.01715","article-title":"Managing central nervous system spread of lung cancer: the state of the art","volume":"40","author":"Tsui","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.116191_bib37","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1470-2045(17)30429-1","article-title":"Dabrafenib plus trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial","volume":"18","author":"Davies","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.116191_bib38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejca.2021.05.005","article-title":"Pyrexia in patients treated with dabrafenib plus trametinib across clinical trials in BRAF-mutant cancers","volume":"153","author":"Schadendorf","year":"2021","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925010779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925010779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:46:40Z","timestamp":1781686000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925010779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":38,"alternative-id":["S0959804925010779"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.116191","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Braf-mutant metastatic non\u2013small-cell lung cancer: Real world data from the Italian biomarker atlas database","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.116191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116191"}}